Skip to content
Catalyst

berberineFinding

Berberine decreases LDL cholesterol

lowersModerate evidenceFindingreplicated ×2

01 · The sentence it was drawn from

“The results demonstrated a significant reduction in LDL-C levels following berberine intervention (SMD = − 0.53, 95% CI [− 0.88, − 0.18], P = 0.003, I2 = 74%; Fig. 8).”
Quoted verbatim from The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.
This finding among the 103 findings on its endpoint

berberine

LDL cholesterol

lowers

Effect as reported

−0.53standardised mean difference

CI −0.88 to −0.18

Who
Adults with NAFLD in pooled RCTs; berberine added to metformin in both-arm-metformin trials (patients with comorbid diabetes) or compared with lifestyle intervention or placebo
Dose studied
berberine 0.6 g to 2 g daily in 9 RCTs, 6.35 g daily in one; 7 to 24 weeks

Moderate evidencePMID 38429794 · 2024

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Journal of translational medicine
What else it reported5 findings · 1 compound · 5 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZAE8DWB30GBXB2QA6HJYT5